The Global Disposable Blood Bags Market, by Blood Bag Type (Collection Bags, Transfer Bags), by End User (Hospitals, Blood Banks, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
was valued at US$ 230.1 million
in 2017, and is projected to exhibit a CAGR of 12.1%
over the forecast period (2018 - 2026), as highlighted in a new report published by .
Blood is essential for surgeries, cancer treatment, chronic illnesses, and traumatic injuries. According to American National Red Cross Blood Organization 2018, sickle cell disease affects 90,000 to 100,000 people in the U.S. Moreover, around 1,000 babies are born with the disease every year. Sickle cell patients often require blood transfusions throughout their lives.
Increasing incidence of cancer cases rises high demand for blood transfusion, which is an important factor impacting growth of the market. According to American Cancer Society, nearly 1.7 million people were diagnosed with cancer in 2017. Many of them needed blood, sometimes daily, during their chemotherapy treatment. Moreover, growing initiatives from governments and healthcare governing bodies for promoting voluntary blood donation, blood collection, and storage, is expected to drive growth of the disposable blood bags market during the forecast years.
Usage of disposable blood bags eliminates the possibility of any contamination as in case of glass bottles. In recent times, disposable blood bags have gained popularity in hospitals and blood banks to meet blood infusion emergencies. According to American National Red Cross Blood Organization 2018 report, every two seconds someone in the U.S. needs blood. According to the same source, around 36,000 units of red blood cells, nearly 7,000 units of platelets, and 10,000 units of plasma are required daily in the U.S.
Browse 23 Market Data Tables and 24 Figures spread through 145 Pages and in-depth TOC on "Disposable Blood Bags Market, by Blood Bag Type (Collection Bags, Transfer Bags), by End User (Hospitals, Blood Banks, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"
To know the latest trends and insights related to disposable blood bags market, click the link below:
Manufacturers in disposable blood bags market are focused on expanding their business in emerging economies such as India, which offers untapped growth opportunities due to its increasing population. Emergence of private insurance services, especially through corporatization and commercialization, has contributed to the transformation of medical sector in emerging economies.
Rapid commercialization of medical practices with the establishment of multimillion hospitals, nursing homes, and diagnostic centers, demand for disposable blood bags has registered huge growth rate in the recent years. There is huge scope and market potential for new manufacturers to venture into the field. Moreover, government support for increasing usage of biocompatible and development of low price blood bags encourage manufacturers to develop new and low cost products.
Key Takeaways of the Disposable Blood Bags Market:
- The global disposable blood bags market is expected to expand at a CAGR of 12.1% during the forecast period (2018–2026), owing to rising demand for blood transfusion with increasing number of blood disorders and road accidents. According to Association for Safe International Road Travel 2018, nearly 1.3 million people die in road crashes each year, causing an average of 3,287 deaths a day globally.
- Among blood bag type, collection bags is expected to hold the major revenue share in 2018, owing to increasing usage in blood donations camps coupled with rising awareness about blood donations
- Among end user, the blood bank segment is expected to grow at the highest rate by 2026, owing to establishment of new blood banks in emerging economies
- Major players operating in the global disposable blood bags market include AdvacarePharma, Fresenius Kabi, Grifols, HLL Lifecare, Haemonetics Corporation, Macopharma, Neomedic, Poly Medicure, SURU International, Span Healthcare, and TERUMO PENPOL